Skip to content

SION SION Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$12.98M+46.7%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$463.5M-6.0%

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.86B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The official record: SION’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's operating lease liabilities (total)?
SION (SION) reported operating lease liabilities (total) of $8.68M in Q4 2025.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.